ROYALTY ASSIGNMENT TERMINATION AGREEMENTRoyalty Assignment Termination Agreement • February 11th, 2011 • Biovest International Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 11th, 2011 Company Industry JurisdictionTHIS ROYALTY ASSIGNMENT TERMINATION AGREEMENT (this “Agreement”) is made as of November 17, 2010, by and among ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation (“Accentia”), BIOVEST INTERNATIONAL, INC., a Delaware corporation (“Biovest”), ERATO CORP. (“Erato”), VALENS U.S. SPV I, LLC (“Valens U.S.”), VALENS OFFSHORE SPV I, LTD. (“Valens Offshore”), and PSOURCE STRUCTURED DEBT LIMITED (“PSource” and together with Erato, Valens U.S. and Valens Offshore, the “Assignees”).